DOI:

Tools & Techniques: aortoiliac and common femoral endovascular interventions

Robert Francis Bonvini, MD; Marco Roffi*, MD, FESC, FACC

This article in the EuroIntervention Tools & Techniques series provides the “How-to-do” aortoiliac and common femoral endovascular interventions. The complete, unabridged e-version with dynamic images can be viewed at www.eurointervention.org. The following is a summary and highlights the key approach that underpins a safe practice and the way to obtain good results.

The infrarenal abdominal aorta and iliac arteries are among the most common sites of chronic obliterative atherosclerosis, accounting for about one-third of all symptomatic peripheral artery disease (PAD) cases. The percutaneous approach has become the treatment of choice for the majority of patients presenting with atherosclerotic aortoiliac disease. The TransAtlantic Inter-Society Consensus (TASC) working group published in the year 2007 an update of the management of PAD, including classification and interventional guidelines of aortoiliac disease (Figure 1).

Figure 1. TransAtlantic Inter-Society Consensus (TASC II) morphologic stratification of iliac lesions.

Currently, percutaneous transluminal angioplasty (PTA) ±stenting has become the treatment of choice for short abdominal aortic stenosis in the absence of significant iliac disease, while surgery should be proposed for distal aortic occlusion (i.e., Leriche syndrome). Access is usually gained using the single retrograde common femoral artery (CFA) approach. On occasion a bilateral retrograde CFA access may be used if balloon dilatation or stent expansion is performed with a double balloon technique or a further brachial access may be necessary to recanalise complex aortic occlusions (Figure 2).

Figure 2. Complete occlusion of the distal abdominal aorta (Leriche Syndrome: arrow) with abundant collateralisation via the inferior mesenteric artery (IMA) and the lumbar artery (LA) (upper panel left). After successful antegrade recanalisation (brachial access), implantation of two large self-expanding stents at the common iliac artery (CIA) level and kissing balloon dilatation (one brachial, the other femoral access) (upper panel right). Final stent implantation at the distal aorta level with final balloon inflation at that level (lower panel left). Final angiographic results show very good results at the distal aorta and the right CIA ostium, and 30% residual stenosis at the left CIA ostium (lower panel right). Ao: abdominal aorta.

Ostial lesions of the common iliac artery are best approached using an ipsilateral retrograde CFA access because an optimal stent placement using the crossover approach may result challenging. Reconstruction of the aortic bifurcation is usually performed with kissing angioplasty/stenting. Simultaneous balloon/stent inflation at the level of the aortic bifurcation is aimed to prevent plaque shift in patients with severe bilateral ostial iliac disease (Figure 3).

Figure 3. Significant stenosis of the ostia of both common iliac arteries (CIA) (upper panel left: arrows). Simultaneous kissing stenting of both common iliac artery ostia (upper panel right), in order to minimise the risk of significant plaque shifting. The stent struts are not protruding in the distal aorta, thus allowing future crossover manoeuvres (lower panel left: arrow). Final angiographic result (lower panel right). Ao: abdominal aorta.

In the presence of a stenosis located in the distal portion of the external iliac artery or the proximal segment of the CFA, the retrograde approach should not be used due to the immediate proximity between the access site and the lesion. Therefore, access should be gained using a crossover technique. For lesions of the CFA, surgery should be considered the therapy of choice, as it may be performed with local anaesthesia, may yield good results, and does not jeopardise future access. If a percutaneous intervention is performed, the contralateral approach is mandatory and a debulking strategy with atherectomy devices may be preferred in order to minimise the need of stent placement and to reduce any potential plaque shift into the profunda femoral artery.

Stenting is recommended for the treatment of iliac long or ostial lesions, total occlusions, and for suboptimal PTA results. Alternatively, stenting is regarded as default strategy by many investigators. Regarding stent type, the high radial strength of balloon-expandable stents and the lack of foreshortening make them suitable in particular for ostial or severely calcified iliac lesions. The greater flexibility and conformability of self-expanding stents apply well to long lesions in tortuous segments. With respect to CFA interventions, stenting should be avoided whenever possible, in order to prevent crushing and to preserve future vascular access.

Volume 6 Number 2
Jun 30, 2010
Volume 6 Number 2
View full issue


Key metrics

Suggested by Cory

EXPERT REVIEW

10.4244/EIJV11I7A164 Nov 20, 2015
Guidewires for lower extremity artery angioplasty: a review
Lorenzoni R et al
free

May 25, 2010
Echocardiography: guidance during valve implantation
Gonçalves A et al
free

Jan 11, 2011
Advanced Bifurcation Systems' mother-daughter platform
Khorsandi M et al
free

10.4244/EIJV16I9A130 Oct 9, 2020
A call for standardisation of vascular access in transcatheter cardiovascular procedures
Burzotta F and Dudek D
free

Original Research

10.4244/EIJ-D-24-00037 Sep 16, 2024
Treatment extent of femoropopliteal disease and clinical outcomes following endovascular therapy
Yoon Y et al
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved